Showing 551-560 of 20873 results for "".
- Community Interventions in Diabetes: New Insightshttps://reachmd.com/news/community-interventions-in-diabetes-new-insights/2485215/In Kalasin Province, a community-based health care program delivering structured self-management support and local health-worker follow-up to adults with u
- GLP-1 Receptor Agonists Not Linked to Increased Melanoma Risk in T2Dhttps://reachmd.com/news/glp-1-receptor-agonists-not-linked-to-increased-melanoma-risk-in-t2d/2488105/GLP-1 receptor agonist (GLP-1RA) therapy was not associated with an increased risk of melanoma among adults with type 2 diabetes (T2D) in a large target trial emulation published in Diabetes, Obesity and Metabolism. GLP-1RA Use and Skin Cancer Risk Investigators used TriN
- Prenatal Strength Training May Lower Gestational Diabetes Riskhttps://reachmd.com/news/prenatal-strength-training-may-lower-gestational-diabetes-risk/2488244/Key Takeaways In the primary intention-to-treat analysis, gestational diabetes occurred in 2% of the strength training group versus 7.3% of the control group, but the difference did not reach statistical significance. In an exploratory per-protocol analysis, gestatio
- US Diabetic Retinopathy Care Cascade Shows Major Drop-Offshttps://reachmd.com/news/us-diabetic-retinopathy-care-cascade-shows-major-drop-offs/2487461/Key Takeaways Screening varied widely, but the sharpest disengagement appeared after diagnosis and during ongoing care. A large share of people with diabetic retinopathy were unaware of the diagnosis, and initial linkage from primary care remained limi
- GLP‑1RA Switching and Treatment Persistence in Adults Without Diabeteshttps://reachmd.com/news/glp1ra-switching-and-treatment-persistence-in-adults-without-diabetes/2486029/Real-world use of GLP-1 receptor agonists for weight management among adults without diabetes was described as non-linear, with medication changes and limited one-year continuation in an insurance-claims dataset. In a recent report on
- Nutritional Strategies in Managing Multiple Sclerosis and Diabetes: A Chronic Disease Perspectivehttps://reachmd.com/news/nutritional-strategies-in-managing-multiple-sclerosis-and-diabetes-a-chronic-disease-perspective/2483068/In an era where chronic diseases like Multiple Sclerosis (MS) and diabetes challenge traditional management, nutrition emerges as a vanguard in modulating disease pathways and improving patient outcomes. Building on nutrition's role in modulating disease pathways, th
- Repurposing HIV Drugs and AI Techs Transform Diabetic Eye Carehttps://reachmd.com/news/repurposing-hiv-drugs-and-ai-techs-transform-diabetic-eye-care/2474883/Despite advances in treatment options, the high cost and limited access to current therapies leave many patients with diabetic eye disease at risk of vision loss, but new approaches involving repurposed HIV drugs and AI technologies are being
- Unveiling Sex Differences in Diabetes Management: Toward Personalized Carehttps://reachmd.com/news/unveiling-sex-differences-in-diabetes-management-toward-personalized-care/2474559/Emerging research reveals that diabetes outcomes differ markedly between men and women, influenced by a complex interplay of biological and sociocultural factors. Recognizing these differences is essential for developing personalized treatment strategies that enhance patient car
- Diabetic Foot Ulcer Prevention: Evaluating Healthcare Practitioner Knowledge in South Africahttps://reachmd.com/news/diabetic-foot-ulcer-prevention-evaluating-healthcare-practitioner-knowledge-in-south-africa/2474184/An insightful survey from the Charlotte Maxeke Johannesburg Academic Hospital Cluster reveals critical differences in diabetic foot ulcer (DFU) prevention knowledge among South African healthcare providers. This prompt for educational advancements entails enhancing
- How Early-Life Gut Microbes Shape Diabetes Protectionhttps://reachmd.com/news/how-early-life-gut-microbes-shape-diabetes-protection/2471580/Recent preclinical mouse studies indicate that the composition of the gut microbiome during infancy is crucial for the proper development of insulin-producing cells, setting the stage for lasting metabolic health and reduced diabetes risk. Over